|
Volumn 38, Issue 12, 2000, Pages 89-93
|
Drug treatment of neuropathic pain
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANALGESIC AGENT;
ANTICONVULSIVE AGENT;
BACLOFEN;
CAPSAICIN;
CARBAMAZEPINE;
CITALOPRAM;
DIAMORPHINE;
FENTANYL;
FLUOXETINE;
GABAPENTIN;
IBUPROFEN;
LAMOTRIGINE;
LIDOCAINE;
MAPROTILINE;
MEXILETINE;
MIANSERIN;
MORPHINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
NORADRENALIN;
NORTRIPTYLINE;
OPIATE;
PAROXETINE;
PHENYTOIN;
PLACEBO;
SEROTONIN;
SULINDAC;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VALPROIC ACID;
ABDOMINAL PAIN;
ANALGESIA;
ARTICLE;
ATAXIA;
AXONAL INJURY;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC NEUROPATHY;
DROWSINESS;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RESPONSE;
HEADACHE;
HEART PALPITATION;
HUMAN;
MEMBRANE STABILIZATION;
MOTOR DYSFUNCTION;
NAUSEA;
NERVE EXCITABILITY;
NEUROTRANSMITTER UPTAKE;
PAIN;
PATIENT INFORMATION;
PERIPHERAL NEUROPATHY;
SENSORY NERVE;
SIDE EFFECT;
SPINAL CORD NERVE CELL;
STEVENS JOHNSON SYNDROME;
TREMOR;
VERTIGO;
VISUAL IMPAIRMENT;
XEROSTOMIA;
|
EID: 0034529302
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.2000.381289 Document Type: Article |
Times cited : (14)
|
References (37)
|